ArticleFrontiers in oncology2026
Uterine smooth muscle tumor of uncertain malignant potential: a case report.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Uterine smooth muscle tumor of uncertain malignant potential (STUMP) is a rare borderline smooth muscle tumor. This paper reports a case of STUMP and discusses its clinical characteristics, diagnostic challenges, and treatment strategies in combination with relevant literature. The patient was a young female who presented with menorrhagia and severe anemia. Pelvic ultrasound revealed a large mass in the uterus, which was suspected to be a uterine leiomyoma. Surgical resection of the mass was subsequently performed, and postoperative pathological examination confirmed the diagnosis of STUMP. The risk factors and biological mechanisms underlying the development of STUMP remain poorly understood. The tumor lacks specific clinical and imaging features, making diagnosis primarily dependent on histopathological evaluation. Surgery is the mainstay of treatment, and close follow-up is recommended postoperatively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.